From NAFLD to MASLD: implications of the new nomenclature for preclinical and clinical research-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

From NAFLD to MASLD: implications of the new nomenclature for preclinical and clinical research

Published:2024-02-21 Issue:4 Volume:6 Page:600-602
ISSN:2522-5812
Container-title:Nature Metabolism
language:en
Short-container-title:Nat Metab

Author:

Hsu Cynthia L.^ORCID,Loomba Rohit^ORCID

Funder

U.S. Department of Health & Human Services | NIH | National Institute of Environmental Health Sciences

U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences

U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute

U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism

American Association for the Study of Liver Diseases

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s42255-024-00985-1.pdf

Reference14 articles.

1. Rinella, M. E. et al. J. Hepatol. 79, 1542–1556 (2023).

2. Kanwal, F., Neuschwander-Tetri, B. A., Loomba, R. & Rinella, M. E. Hepatology https://doi.org/10.1097/HEP.0000000000000670 (2023).

3. Ratziu, V. & Boursier, J. J. Hepatol. 80, e51–e52 (2023).

4. Song, S. J., Che-To Lai, J., Lai-Hung Wong, G., Wai-Sun Wong, V. & Cheuk-Fung Yip, T. J. Hepatol. 80, e54–e56 (2023).

5. Hagstrom, H., Vessby, J., Ekstedt, M. & Shang, Y. J. Hepatol. 80, e76–e77 (2023).

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic syndrome traits differentially and cumulatively influence micro‐ and macrovascular disease risk in patients with MASLD;Liver International;2024-09-02

2. Lingguizhugan oral solution alleviates MASLD by regulating bile acids metabolism and the gut microbiota through activating FXR/TGR5 signaling pathways;Frontiers in Pharmacology;2024-08-15

3. Prevalence of steatotic liver disease, advanced fibrosis and cirrhosis among community-dwelling overweight and obese individuals in the USA;Gut;2024-08-07

4. Amelioration of nonalcoholic fatty liver disease by inhibiting the deubiquitylating enzyme RPN11;Cell Metabolism;2024-08

5. Quantitative Liver Imaging in Children;Investigative Radiology;2024-07-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3